Kadri AN, Wilner B, Hernandez AV, Nakhoul G, Chahine J, Griffin B, Pettersson G, Grimm R, Navia J, Gordon S. Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016. J Am Heart Assoc. 2019;8: e012969.
Article PubMed PubMed Central Google Scholar
Ali SFB, Dharani S, Afrooz H, Mohamed EM, Cook P, Khan MA, Rahman Z. Development of abuse-deterrent formulations using sucrose acetate isobutyrate. AAPS PharmSciTech. 2020;21:1–14.
Hale ME, Moe D, Bond M, Gasior M, Malamut R. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain. Pain Manag. 2016;6:497–508.
Rana D, Salave S, Benival D. Emerging trends in abuse-deterrent formulations: Technological insights and regulatory considerations. Curr Drug Deliv. 2022;19:846–59.
Article CAS PubMed Google Scholar
Hamed E, Moe D. Development of tamper deterrent formulations: state of the pharmaceutical industry. Curr Drug Abuse Rev. 2010;3:139–46.
Article CAS PubMed Google Scholar
Salem S, Byrn SR, Smith DT, Gurvich VJ, Hoag SW, Zhang F, Williams RO III, Clase KL. Impact assessment of the variables affecting the drug release and extraction of polyethylene oxide based tablets. J Drug Deliv Sci Technol. 2022;71: 103337.
Ahmad R, Alaei S, Omidian H. Safety and performance of current abuse-deterrent formulations. Expert Opin Drug Metab Toxicol. 2018;14:1255–71.
Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 2: commercial products and proprietary technologies. Expert Opin Pharmacother. 2015;16:305–23.
Article CAS PubMed Google Scholar
Boyce H, Smith D, Byrn S, Saluja B, Qu W, Gurvich VJ, Hoag SW. In vitro assessment of nasal insufflation of comminuted drug products designed as abuse deterrent using the vertical diffusion cell. AAPS PharmSciTech. 2018;19:1744–57.
Article CAS PubMed Google Scholar
Meruva S, Donovan MD. Effects of drug-polymer interactions on tablet properties during the development of abuse-deterrent dosage forms. AAPS PharmSciTech. 2019;20:93.
Article CAS PubMed Google Scholar
Meruva S, Donovan MD. Polyethylene oxide (PEO) molecular weight effects on abuse-deterrent properties of matrix tablets. AAPS PharmSciTech. 2020;21:1–10.
Rahman Z, Aqueel MS, Korang-Yeboah M, Zidan AS, Chen J, Alayoubi AY, Cruz CN, Ashraf M. Evaluation of commercially available meth-deterrent pseudoephedrine hydrochloride products. Int J Pharm. 2020;575: 118909.
Article CAS PubMed Google Scholar
Rezaei L, Meruva S, Donovan MD. Effect of manufacturing process on the retention of abuse-deterrent properties of PEO-matrix tablets. AAPS PharmSciTech. 2022;23:1–11.
Presley B, Bianchi B, Coleman J, Diamond F, McNally G. Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper-resistant and non-tamper-resistant formulations. J Pharm Biomed Anal. 2018;156:16–22.
Article CAS PubMed Google Scholar
Ahmad R, Omidian H. Development and in vitro evaluation of an abuse-deterrent formulation based on a crosslinked starch derivative. Int J Pharm. 2019;569: 118602.
Article CAS PubMed Google Scholar
Palekar S, Nukala PK, Vartak R, Patel K. Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse. Int J Pharm. 2020;590: 119944.
Article CAS PubMed Google Scholar
Sohn JS, Choi J-S. Development and evaluation of pseudoephedrine hydrochloride abuse-deterrent formulations using thermal modified rice starch. Int J Biol Macromol. 2021;182:1248–58.
Article CAS PubMed Google Scholar
Chen F, Xie F, Liu P, Chen P. Structure, thermal stability and suspension rheological properties of alcohol–alkali-treated waxy rice starch. Int J Biol Macromol. 2019;134:397–404.
Article CAS PubMed Google Scholar
Yang L, Zhou Y, Wu Y, Meng X, Jiang Y, Zhang H, Wang H. Preparation and physicochemical properties of three types of modified glutinous rice starches. Carbohydr Polym. 2016;137:305–13.
Article CAS PubMed Google Scholar
Svačinová P, Mužíková J, Ondrejček P. Comparison of compressibility, compactability, and lubricant sensitivity of two partially pregelatinized starches. Starch-Stärke. 2021;73:2000166.
Berardi A, Janssen PH, Dickhoff BH. Technical insight into potential functional-related characteristics (FRCs) of sodium starch glycolate, croscarmellose sodium and crospovidone. J Drug Deliv Sci Technol. 2022;103261.
Aburahma MH, Badr-Eldin SM. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv. 2014;11:1865–83.
Article CAS PubMed Google Scholar
Boumrah Y, Bouzahia I, Bouanani S, Khimeche K, Dahmani A. Thermodynamic and analytical studies of drugs binary systems of paracetamol mixed with pseudoephedrine. HCl, dextropropoxyphene. HCl and tramadol HCl Thermochim Acta. 2016;634:48–56.
Barakh Ali SF, Dharani S, Afrooz H, Mohamed EM, Cook P, Khan MA, Rahman Z. Development of abuse-deterrent formulations using sucrose acetate isobutyrate. AAPS PharmSciTech. 2020;21:1–14.
Rahman Z, Yang Y, Korang-Yeboah M, Siddiqui A, Xu X, Ashraf M, Khan MA. Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations. Int J Pharm. 2016;502:138–50.
Article CAS PubMed Google Scholar
Rahman Z, Zidan AS, Korang-Yeboah M, Yang Y, Siddiqui A, Shakleya D, Khan MA, Cruz C, Ashraf M. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets. Int J Pharm. 2017;517:303–11.
留言 (0)